News | Colonoscopy Systems | July 12, 2017

Insurance Coverage for CT Colonography Increases Likelihood of Screening

Study finds those covered for CTC were 50 percent more likely to receive any form of screening

Insurance Coverage for CT Colonography Increases Likelihood of Screening

July 12, 2017 — People with insurance policies that cover computed tomography (CT) colonography for colorectal cancer screening are almost 50 percent more likely to get screened than those whose policies don’t cover the procedure, according to a new study appearing online in the journal Radiology.

Colorectal cancer kills 50,000 people each year, despite the existence of screening methods that provide early detection and treatment of the disease. The American Cancer Society recommends CT colonography as one of the screening tests that can find both pre-cancerous polyps and cancer in people age 50 or older, but insurers have been slow to cover it. CT colonography, also known as virtual colonoscopy, uses CT imaging to provide fly-through views of the colon and is a less invasive option than conventional colonoscopy.

Meanwhile, screening adherence rates have stalled at about two-thirds of the people who need to be screened, according to study lead author Maureen A. Smith, M.D., Ph.D., MPH, from the University of Wisconsin-Madison School of Medicine and Public Health in Madison, Wis.

“CT colonography is a newer technology that can detect both pre-cancer and cancer, but because it’s relatively new it isn’t widely covered by insurance and isn’t covered by Medicare,” Smith said.

Smith and colleagues recently examined whether changing insurance benefits to cover CT colonography for screening might help improve screening rates.

The researchers looked at overall colorectal cancer screening rates for 33,177 patients under age 65 who were eligible and due for colorectal cancer screening. About half of the people in the group were ultimately screened during the study period, and researchers compared screening rates between those with and without insurance coverage for CT colonography.

Data analysis showed that the people in the study who had insurance coverage for CT colonography had a 48 percent greater likelihood of being screened by any method compared with those without coverage who were due for screening.

“Our study suggests that when people are offered a greater choice of screening tests for colorectal cancer, including CT colonography, they are more likely to complete screening to prevent colorectal cancer,” Smith said.

Smith said the study findings represent another piece of the puzzle in getting people to follow screening recommendations — a particularly important challenge in groups that traditionally have lower screening rates, such as people in rural areas, racial/ethnic minorities and people with lower incomes.

“Policymakers should consider additional options for screening and prevention of colorectal cancer,” Smith said. “CT colonography is potentially a powerful option, because there are people who will prefer it.”

Some insurers have begun increasing coverage to include CT colonography, Smith said, but the lack of coverage by Medicare is unlikely to change soon.

“Locally, insurers have been open to including CT colonography in their coverage,” she said. “Nationally, any change will probably rely on Medicare’s decision-making process, which can take substantially more time.”

Read the article “The Future of CT Colonography Screening.”

For more information: www.pubs.rsna.org/journal/radiology

Related Content

International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
Aidoc Earns FDA Approval for AI for C-spine Fractures
Technology | Artificial Intelligence | June 11, 2019
Radiology artificial intelligence (AI) provider Aidoc announced the U.S. Food and Drug Administration (FDA) has cleared...
SCCT Announces 2019 Gold Medal Award Recipients
News | Computed Tomography (CT) | June 05, 2019
The Society of Cardiovascular Computed Tomography (SCCT) will present the 2019 Gold Medal Award to Jonathon Leipsic, M....
AI Biomarker Demonstrates High Predictive Power for Lung Cancer Immunotherapy
News | Artificial Intelligence | May 31, 2019
Lunit announced an abstract presentation of its artificial intelligence (AI) precision medicine research portfolio at...
Einstein Healthcare Network found that use of automated power injectors reduced CT contrast extravasation rates over a 30-month period.

Einstein Healthcare Network found that use of automated power injectors reduced CT contrast extravasation rates over a 30-month period.

Feature | Computed Tomography (CT) | May 30, 2019 | By Jeff Zagoudis
As of 2015, approximately 79 million computed tomography (CT) scans were performed each year in the U.S.
Sponsored Content | Webinar | Computed Tomography (CT) | May 30, 2019
This webinar will explain technical considerations when performing cardiac CT angiography in pediatric patients.
Sponsored Content | Webinar | Computed Tomography (CT) | May 30, 2019
Chest pain is one of the most frequent reasons for an evaluation in the emergency room.There are multiple imaging mod
Dynamic Digital Radiography Used to Assess Undifferentiated Dyspnea
News | Digital Radiography (DR) | May 29, 2019
A clinical study presented at the American Thoracic Society (ATS) 2019 annual meeting, May 17-22 in Dallas, described...
Vast Majority of Heavy Smokers Not Screened for Lung Cancer
News | Lung Cancer | May 29, 2019
Out of more than 7 million current and former heavy smokers, only 1.9 percent were screened for lung cancer in 2016...
Leica Biosystems Receives FDA Clearance for Aperio AT2 DX Digital Pathology System
Technology | Digital Pathology | May 29, 2019
Leica Biosystems has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX...